Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-46 PET in GI and Ovarian Cancers
NCT05172310Phase 1Recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Diagnostic accuracy of FAPI-PET/CT in primary tumors up to 18 months. Started Jun 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05172310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172310.